Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin T. Diamond, Paolo Corradini, David Glen Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, , Alessandra Larocca
This study identifies genomic and immune factors associated with resistance to anti-CD38 therapy in multiple myeloma patients.
medRxiv · Dec 4, 2023 · PreprintGenetic & Genomic Medicine